Crinetics Pharmaceuticals, Inc. — Operating Income by Fiscal Year
10 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/5c2284b2-824f-4875-ab2b-8c7dc9286066/serie/operating-income
| Fiscal year | Operating Income | Period | Evidence |
|---|---|---|---|
| FY 2025 | $-516.8M | 2025-01-01 – 2025-12-31 | evidence 0001658247-26-000012 |
| FY 2024 | $-338.9M | 2024-01-01 – 2024-12-31 | evidence 0000950170-25-029050 |
| FY 2023 | $-222.6M | 2023-01-01 – 2023-12-31 | evidence 0000950170-24-022108 |
| FY 2022 | $-167.9M | 2022-01-01 – 2022-12-31 | evidence 0000950170-23-005132 |
| FY 2021 | $-107.7M | 2021-01-01 – 2021-12-31 | evidence 0000950170-22-005050 |
| FY 2020 | $-75.0M | 2020-01-01 – 2020-12-31 | evidence 0001564590-21-016719 |
| FY 2019 | $-53.8M | 2019-01-01 – 2019-12-31 | evidence 0001564590-20-009365 |
| FY 2018 | $-28.7M | 2018-01-01 – 2018-12-31 | evidence 0001564590-19-007561 |
| FY 2017 | $-9.1M | 2017-01-01 – 2017-12-31 | evidence 0001564590-19-007561 |
| FY 2016 | $-6.0M | 2016-01-01 – 2016-12-31 | evidence 0001564590-19-007561 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Crinetics Pharmaceuticals, Inc. — all facts · Revenue · Net Income